Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; pp. v329 - v330
Main Authors: Tagawa, S.T., Osborne, J.R., Hackett, A., Niaz, M.J., Cooley, V., Christos, P., Vlachostergios, P.J., Thomas, C., Gracey, L., Beltran, H., Molina, A.M., Nanus, D.M., Babich, J., Vallabhajosula, S., Sartor, O., Ballman, K., Bander, N.H.
Format: Journal Article
Language:English
Published: 01-10-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1093/annonc/mdz248.006